Glycemic Management in ESRD and Earlier Stages of CKD
- 1 February 2014
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 63 (2) , S22-S38
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 124 references indexed in Scilit:
- Comparative effectiveness of incident oral antidiabetic drugs on kidney functionKidney International, 2012
- Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney DiseaseArchives of internal medicine (1960), 2011
- Tracing the footsteps of glomerular insulin signaling in diabetic kidney diseaseKidney International, 2011
- Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesityKidney International, 2011
- Effect of renal impairment on the pharmacokinetics of the GLP‐1 analogue liraglutideBritish Journal of Clinical Pharmacology, 2009
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)The Lancet, 2009
- Glucose Control and Vascular Complications in Veterans with Type 2 DiabetesNew England Journal of Medicine, 2009
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Effect of renal impairment on the pharmacokinetics of exenatideBritish Journal of Clinical Pharmacology, 2007